The addition of Cianna would give Merit a boost in the wire-free breast localization market.
Medtronic is the undisputed leader of the drug-coated balloon space, but Philips is vying for an indication that could potentially impact the Dublin-based firm’s hold on the market.
The release of the ST LEUIS trial data comes on the heels of Apple receiving FDA clearance for an ECG app for the Apple Watch.
The Danvers, MA had strong data at the American Heart Association, however the firm’s shares were down as much as 17% on Monday.
Medical professionals across the country are standing up to the National Rifle Association after the organization told doctors to "stay in their lane." Will medtech take a stand on the issue?
The London-based company’s bioconvertible IVC filter had zero instances of tilt, perforation, migration and embolization through follow-up in the SENTRY trial.
The Santa Clara, CA-based company filed its PMA submission with FDA earlier this year and hopes to be able to launch the technology in the first half of 2019.
Undergoing emergency gallbladder surgery gave News Editor Amanda Pedersen an eye-opening view of the current state of the U.S. healthcare system.
Establish a supportive vendor relationship by providing exceptional training during device installations.
The Louisville, CO-based company has raised $7.5 million and will use the new capital to help with regulatory approval and the commercial launch of the system.
The Dublin-based company has received FDA approval to begin a clinical trial to evaluate the Symplicity Spyral renal denervation system with patients on medication for high blood pressure.
The San Diego-based company brought in about $266.7 million in revenue vs. the consensus estimate of $241.3 million.
FDA has given approval for the Germantown, MD-based company’s device to be inserted by qualified nurse practitioners and physician assistants.
The Redwood City, CA-based company spent about $3.5 million in its patent dispute with Boston Scientific during 3Q18.